Concepedia
Statistics
Publications
8
Citations
313
H-Index
Active since
2014
Affiliations
Sanofi (United States)(Current)
Regeneron (United States)
Sanofi (France)
University of Colorado Denver
National Jewish Health
Xuezhou Mao is an author at Sanofi (United States) specializing in clinical trials, public health, and biostatistics.
Publications per year
2014–2024
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
Tanya M. Laidlaw, Claus Bachert, Nikhil Amin et al. · Annals of Allergy Asthma & Immunology · 2021 · 104 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma
Leonard B. Bacharier, Ian Pavord, Jorge Máspero et al. · Journal of Allergy and Clinical Immunology · 2024 · 51 citations · Full text
Medicine, Immunology, Pediatrics +17
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma
Lawrence Sher, Michael E. Wechsler, Klaus F. Rabe et al. · CHEST Journal · 2022 · 44 citations · Full text
Pharmacy, Immunology, Pharmacology +11
Multi-regional clinical trial design and consistency assessment of treatment effects
Hui Quan, Xuezhou Mao, Joshua Chen et al. · Statistics in Medicine · 2014 · 31 citations
Public Health, Biostatistics, Epidemiologic Methods +15
Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis
Shifen Dong, Rong Zhang, Yaoyue Liang et al. · Diabetology & Metabolic Syndrome · 2017 · 27 citations · Full text
Life Sciences, Biochemistry, Cardiology +17
1–5 of 8